Home›Companies›Biotech & Pharma›Balanced Pharma

Balanced Pharma Inc

Updated Oct 27, 2026·Latest SEC filing Sep 23, 2025·Suggest an edit

About Balanced Pharma

Balanced Pharma is a private company based in Cornelius, North Carolina, incorporated in 2020 in Delaware. It has reported $5,884,300 raised in four offerings on Form D since January 2021.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 31, 2024Jan 15, 2025$175,000of $2.0M target2$87,500EquityRule 506(b)Form D ↗
Nov 27, 2024Dec 12, 2024amended Sep 23, 2025$3,200,000fully sold1$3.2MEquityRule 506(b)Form D/A ↗1 earlier filing
Dec 12, 2024Dec 12, 2024$498,000fully sold19$26,211EquityRule 506(b)Form D ↗
Dec 16, 2020Jan 7, 2021amended Feb 18, 2022$2,011,300fully sold44$45,711EquityRule 506(b)Form D/A ↗1 earlier filing
Total, four offerings$5,884,300

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Balanced Pharma's Form D filed Jan 15, 2025.

MS
Mark Sebree
Director
JK
John Keadle
President and director
JS
John Selig
Director
AZ
Atif Zia
Director
RN

Sources

  1. SECBalanced Pharma Inc Form D, filed Dec 12, 2024
  2. SECBalanced Pharma Inc Form D, filed Jan 7, 2021
  3. SECBalanced Pharma Inc filing history